C07K 11/02
Cyclic
Official title: cyclic, e.g. valinomycins {; Derivatives thereof}
C07K11/02 (Cyclic) appears on 178 US grants and 212 published applications in this corpus.
Search patents in C07K- Granted patents
- 178
- Published applications
- 212
- Assignees
- 125
- Inventors
- 639
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 6 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 5 |
| 2003 | 4 | 6 |
| 2004 | 6 | 2 |
| 2005 | 1 | 4 |
| 2006 | 5 | 4 |
| 2007 | 2 | 2 |
| 2008 | 3 | 4 |
| 2009 | 1 | 3 |
| 2010 | 2 | 7 |
| 2011 | 1 | 2 |
| 2012 | 4 | 6 |
| 2013 | 3 | 4 |
| 2014 | 8 | 17 |
| 2015 | 9 | 16 |
| 2016 | 13 | 10 |
| 2017 | 6 | 13 |
| 2018 | 9 | 10 |
| 2019 | 7 | 13 |
| 2020 | 9 | 16 |
| 2021 | 10 | 14 |
| 2022 | 10 | 17 |
| 2023 | 11 | 12 |
| 2024 | 7 | 9 |
| 2025 | 9 | 10 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Paenibacillus strain, antifungal compounds, and methods for their use6 Oct 2026US 12,753,207 B2Bayer CropScience AG
- Compounds for use in viral infections19 May 2026US 12,630,589 B2Pharma Mar, S. A.
- Heterotandem bicyclic peptide complexes21 Apr 2026US 12,606,594 B2BicycleTx Limited
- Bicyclic peptide ligands specific for EphA210 Mar 2026US 12,570,695 B2BicycleTx Limited
- Macrocyclic compounds as proteasome inhibitors18 Nov 2025US 12,473,331 B2Cornell University
- Improving microbial activity17 Sep 2026US 2026/0275269 A1BASF SE
- Heterologous production of the c33–c45 polyketide fragment of anticancer apratoxins in a cyanobacterial host30 Jul 2026US 2026/0218211 A1Smithsonian Institution
- Cilagicin compounds and methods of use thereof9 Jul 2026US 2026/0193295 A1The Rockefeller University
- Novel Cyclodepsipeptides And Cyclopeptides And Their Use In Therapy25 Jun 2026US 2026/0176304 A1Lifemine Therapeutics, Inc.
- Macrocyclic peptides targeting kras1 Jan 2026US 2026/0001914 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Methods for synthesizing oligomers containing hydroxy acid units56US 5,625,030 AMetabolix, Inc. · 1997
- Depsipeptide and congeners thereof for use as immunosuppressants40US 6,403,555 B1XCYTE Therapies, Inc. · 2002
- Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 1338US 4,986,988 AArizona Board of Regents · 1991
- Cyclosporin peptolides having an .alpha.-hydroxycarboxylic acid at position 838US 5,116,816 ASandoz Ltd. · 1992
- Therapeutic uses of depsipeptides and congeners thereof35US 6,548,479 B1XCYTE Therapies, Inc. · 2003